Department of Hematopathology
|
|
|
Colorado |
Dr. Bitter is board-certified in Anatomic and Clinical Pathology, as well as Hematology. A nationally recognized expert, Dr. Bitter brings extensive experience and leadership in diagnostic hematopathology as head of the Department of Hematopathology at UniPath. After earning a B.A. degree in biology from the State Uinversity of New York at Binghamton, Dr. Bitter earned his M.D. degree in 1978 from the University of Chicago Pritzker School of Medicine, Chicago, Illinois and was also elected to the Alpha Omega Alpha Medical Honor Society. Following a residency in pathology at the University of Colorado Health Sciences Center, Denver, Colorado, Dr. Bitter completed his fellowship in hematopathology at the University of Chicago Medical Center. He was invited to join the faculty at the University of Chicago as Assistant Professor of Pathology; and also served as Assistant Director of Hematopathology. In 1989, Dr. Bitter returned to the University of Colorado Health Sciences Center as Director of Hematopathology and the Clinical Hematology Laboratory; while there, he rose to the rank of Professor of Pathology and developed an active consultation service. He continues to be affiliated with UCHSC as Clinical Professor of Pathology. Dr. Bitter has numerous publications in peer reviewed journals in the areas of leukemia and lymphoma, and is also the author of several book chapters. |
Colorado |
Virginia D. Burdine, M.D., Ph.D. Dr. Burdine is board-certified in Anatomic and Clinical Pathology, with subspecialty board certification in Hematology. After earning a B.S. degree (summa cum laude) in biology and chemistry from Southern Nazarene University, Bethany, Oklahoma, Dr. Burdine received a Ph.D. in molecular and cell biology from the Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center. She received her M.D. degree (with outstanding distinction) in 1997 from the University of Oklahoma Health Sciences Center, College of Medicine. Dr. Burdine completed her residency in Pathology at Penrose Hospital, Colorado Springs, Colorado, and subsequently completed a fellowship in Hematopathology at the University of Wisconsin Hospital & Clinics, Madison, Wisconsin. Prior to joining UniPath, Dr. Burdine has been member of the pathology staff at several hospitals in Tulsa, Oklahoma, including Saint Francis Hospital, Southwestern Regional Medical Center, and Saint Francis Heart Hospital. During her appointments at these hospitals, she served as Medical Director is several areas, including Transfusion Service, the Hematology and Coagulation Laboratories, the Hematopoetic Stem Cell Processing Laboratory, and the Clinical Laboratory. Dr. Burdine is a member of several professional societies including, College of American Pathologists (CAP), United States and Canadian Association of Pathology (USCAP), American Society for Clinical Pathology (ASCP), American Society of Hematology, American Association of Blood Banks, Society for Hematopathology, and Children's Oncology Group. |
Colorado |
Cristina Smith McLaughlin, M.D. Dr. McLaughlin is board-certified in Anatomic and Clinical Pathology. She is also subspecialty board-certified in Hematology. After earning a B.A. in history from Reed College, Dr. McLaughlin received her medical degree in 2004 from the Oregon Health & Sciences University School of Medicine in Portland, Oregon, where she also completed her pathology residency and served as co-chief resident. Dr. McLaughlin completed a surgical pathology fellowship at The Mayo Clinic in Rochester, Minnesota; and then returned to Portland, Oregon to complete a fellowship in Hematopathology at the Oregon Health & Sciences University School of Medicine. Dr. McLaughlin is a member of several professional societies, including CAP, ASCP, USCAP, and the American Society of Cytopathologists. She has also served as CAP junior inspector. Dr. McLaughlin has been involved in several research projects, publications and presentations in pathology. She has also been the recipient of a number of honors and rewards, including American Society of Hematology Scholar, the Alma B. Sneeden Pathology Award, and Collegiate All-American in Women's Rugby while attending Reed College. |
Colorado |
Dr. Miller is board-certified in Anatomic and Clinical Pathology as well as Hematology. Dr. Miller currently serves as Medical Director of Flow Cytometry at UniPath. After earning a B.S. degree cum laude in biology from the University of Colorado at Denver, Dr. Miller earned his M.D. degree from the University of Colorado Health Sciences Center, Denver, Colorado in 2002. He then completed his residency and a fellowship in Hematology at the University of Utah Health Sciences Center, Salt Lake City, Utah. Following his fellowship, Dr. Miller served as staff pathologist for several medical centers and pathology laboratories, including serving as Assistant Medical Director in Hematologic Flow Cytometry at ARUP Laboratories, Salt Lake City, Utah. Dr. Miller has also been a CAP inspector. Dr. Miller has been the recipient of multiple scholastic honors and rewards, including Young Investiators Award by the Academy of Clinical and Laboratory Physicians and Scientists (ACLPS). He has also been involved in multiple research projects and has given numerous presentations in hematology. |
Colorado |
Dr. Yang is board-certified in Anatomic Pathology with additional subspecialty board certifications in Hematology and Dermatopathology. After earning a B.S. in biology from Hangzhou University, China, Dr. Yang completed graduate work in biology at Zhejiang University, China and the University of Florida, and went on to earn a Ph.D. in genetics from SUNY at Stony Brook (Cold Spring Harbor Laboratory). She also completed a post-doctoral fellowship in human genetics at Stanford University, Palo Alto, California. Dr. Yang received her M.D. degree in 2006 from Duke University Medical School in Durham, North Carolina. She then completed her residency in Anatomic Pathology including a three-month soft tissue pathology fellowship, and subsequently a fellowship in Hematopathology at the Department of Pathology, Harvard Medical School / Brigham & Women’s Hospital, Boston, Massachusetts. She has also completed a fellowship in Dermatopathology at The Mayo Clinic, Rochester, Minnesota. Dr. Yang also founded and was the Chief Technology Officer of FreshGene, Inc., Mountain View, California, which was a venture-backed molecular diagnostics company that was acquired by Panomics, Inc. in 2003 which eventually became part of Affymetryx, Inc. in 2007. While at FresGene, Dr. Yang, invented, developed and optimized a new SNP/point mutation genotyping technology with three issued patents. Dr. Yang has been the recipient of multiple scholastic honors and awards, and has been involved in multiple research projects. |
Colorado |
Dr. Lin leads our flow cytometry technical operation as Director of Flow Cytometry. Dr. Lin was most recently Manager, Cell Marker Laboratory, Department of Clinical laboratories at Memorial Sloan-Kettering Cancer Center, New York, N.Y. Previously, Dr. Lin served as Laboratory Supervisor and Research Associate, Cellular Immunology Laboratory, Department of Pediatrics/Division of Hematology/Oncology of Weil Medical College of Cornell University, New York, N.Y. Before that, Dr. Lin was a research associate in Integrative Medicine Service at Memorial Sloan-Kettering Cancer Center. Dr. Lin holds a B.S. degree from Agriculture College, and a Ph.D. from Peking Union Medical College, Beijing, China. She then completed a post-doctoral fellowship at Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan. Dr. Lin received several awards and has published extensively. She is member of the American Association for Cancer Research and an active member of the American Association of Hematology. Dr. Lin has extensive experience in flow cytometric immunophenotyping for leukocytes (lymphocyte subsets, helper/suppressor T cell quantitation, myelomocytic immunophenotyping) and neoplastic hematolymphoid cells (leukemia, lymphoma, T, B, non-lymphoid cells, and Paroxysmal Nocturnal Hemoglobinuria), as well as flow cytometric intracellular cytokine assays, and DNA cell cycle analysis. She also has direct clinical trials experience, having conducted cellular immunological tests for clinical trial “A phase I/II study of Maitake MD-fraction in breast cancer patients”. |
Colorado |
Dr. Payne joined in 2009 to lead our molecular laboratory division and currently serves as Vice President of Molecular Services. She was most recently Director of the Molecular Diagnostic Laboratory of the University of Texas Southwestern Medical Center in Dallas, Texas where she was also Associate Professor of Pathology. She was also Director and a founding member of the Division of Molecular Diagnostics in the Department of Pathology at the University of Texas Medical Branch. Dr. Payne received her Ph.D. in Microbiology and Immunology from the University of Texas Medical Branch in Galveston, Texas; and performed part of her post-doctoral training at the Johnson Space Center in Houston, Texas. Dr. Payne is nationally recognized in molecular diagnostics, is an active speaker, well published and active member of numerous committees and industry organizations. She has held offices as the Chair of the Training and Education Committee for the Association of Molecular Pathology, as Chair of the Molecular Pathology division (2002-2003) for the American Association for Clinical Chemistry (AACC), as the Co-Chair for the NACB Laboratory Practice Guidelines Committee on Pharmacogenetics, as the only U.S. member is on the Committee for Molecular Diagnostics for the International Federation for Clinical Chemistry (IFCC), and as member of the Board of Directors for the American Board of Clinical Chemistry. Dr. Payne is also a member of the Center for Disease Control (CDC) committee on reference materials, an advisor for the Clinical Laboratory Standards Institute (CLSI), and a member of the Board of Directors for the American Board of Clinical Chemistry (ABCC). Dr. Payne also served as a voting member for the Molecular and Clinical Genetics Devices Panel of the Medical Devices Advisory Committee of the Food and Drug Administration (FDA). Dr. Payne has authored or co-authored several book chapters, and 55 manuscripts, and is on the editorial board for LabMedicine. She is certified as a clinical laboratory technologist in Molecular Biology MB(ASCP), holds a Diplomate in Laboratory Management DLM(ASCP). She is also a Fellow of the National Academy of Clinical Biochemistry (FACB), and is board-certified by the American Board of Clinical Chemistry in Molecular Diagnostics (DABCC) and by the American Board of Medical Microbiology (DABCC). |
|
|
|
Florida |
Dr. Sara is board-certified in Anatomic and Clinical Pathology, as well as Cytopathology. Dr. Sara has special interests in urologic pathology and hematopathology. Dr. Sara earned his M.D. degree in 1982 from Damascus University Faculty of Medicine, Damascus, Syria. After a year as a general practicioner at Tuscon General Hospital, Tuscon, Arizona, he completed a residency in Anatomic and Clinical Pathology at the University of South Florida College of Medicine Affiliated Hospitals, Tampa, Florida. Dr. Sara went on to complete a fellowship in Surgical Pathology, Cytology & FNA at the University of Texas M.D. Anderson Cancer Center, Houston, Texas. Following his fellowship, Dr. Sara served as Assistant Professor of Pathology at the University of Miami School of Medicine, Miami, Florida. Dr. Sara is member of several professional organizations, including College of American Pathologists (CAP) and American Society of Clinical Pathologists (ASCP). Dr. Sara is currently a pathology staff member of Palm Beach Gardens Medical Center. |
Florida |
Dr. Zhang is board-certified in Anatomic and Clinical Pathology; as well as subspecialty board-certified in Hematology. Dr. Zhang also has special interest in gastrointestinal pathology. Dr. Zhang earned an M.D. degree in 1985 from Zhejiang Medical University, Hangzhou, China. He then went on to complete a Ph.D. in peptide biochemistry from University of Shizuoka, Shizuoka, Japan. Dr. Zhang held several instructor positions at the Department of Surgery of the University of Texas Medical Branch, Galveston, Texas. He then went on to complete a residency in Anatomic and Clinical Pathology at Barnes-Jewish Hospital of the Washington University Medical Center, St. Louis, Missouri. Following his residency, Dr. Zhang completed a fellowship in Hematopathology at Indiana University Medical Center, Indianapolis, Indiana. Dr. Zhang is member of the pathology medical staff at Good Samaritan Medical Center and St. Mary's Medical Center, West Palm Beach, Florida, where he is also member of the Institutional Review Board. |
| Back to Top |